1cP-AL-LAD 150mcg Blotters

---

1-Cyclopropionyl-6-allyl-6-nor-lysergic acid diethylamide, commonly referred to as 1cP-AL-LAD, is a novel psychedelic substance belonging to the lysergamide class. This compound is closely related to AL-LAD and is suspected to act as a prodrug for it; however, there is currently a lack of data and anecdotal reports to substantiate this claim.

Origins and Synthesis

1cP-AL-LAD is believed to have been synthesized by a small group of chemists who were also responsible for creating various other novel lysergamides, such as 1cP-MiPLA, LSZ, and LST, around 2020 or 2021. However, the validity of this claim remains largely unverified.

User Experiences

User reports suggest that the effects of 1cP-AL-LAD are similar to those of AL-LAD. Some anecdotal evidence indicates that there may be slight differences between the two substances, but this does not rule out the possibility of 1cP-AL-LAD being a true prodrug for AL-LAD. Many effects appear to be nearly identical, including a more manageable mental state, visual experiences, and comparable dosage levels.

Chemical Structure

1cP-AL-LAD is a semisynthetic alkaloid from the lysergamide family. Its structure is a derivative of lysergic acid, featuring an N,N-diethylamide functional group. The compound contains a bicyclic hexahydroindole fused to a bicyclic quinoline group (nor-lysergic acid). Unlike LSD, 1cP-AL-LAD lacks a methyl group at R6 of its nor-lysergic acid skeleton, which is indicated by the "nor-" prefix. Instead, it has an allyl group at R6, consisting of a methylene bridge linked to a vinyl substituent, and a cyclopropionyl substituent at R1. Additionally, a N,N-diethyl carboxamide is attached at carbon 8 of the quinoline.

Chirality

1cP-AL-LAD is a chiral compound with two stereocenters located at R5 and R8. The compound, also known as (+)-D-1cP-AL-LAD, has an absolute configuration of (5R, 8R). The other three stereoisomers of 1cP-AL-LAD are presumed to lack psychoactive properties.

Pharmacological Profile

1cP-AL-LAD is thought to function as a 5-HT2A partial agonist, with its psychedelic effects likely stemming from its interaction with 5-HT2A receptors. However, the precise mechanisms behind these interactions and their contribution to the psychedelic experience remain subjects of ongoing scientific investigation.

Prodrug Hypothesis

There is speculation that 1cP-AL-LAD may act as a prodrug for AL-LAD due to its 1-Cyclopropionyl substitution, similar to how 1cP-LSD is believed to function as a prodrug for LSD. Nonetheless, insufficient data and anecdotal evidence exist to confirm this property for 1cP-AL-LAD.

Comparative Effects

1cP-AL-LAD shares several characteristics with its parent compound, LSD. In human subjects, it appears to have comparable or slightly lower potency, with a similar mechanism of action. However, the onset and duration of effects are generally shorter, while remaining qualitatively less intense and more manageable, possibly due to more rapid catabolism.

Subjective Effects

While the subjective effects of 1cP-AL-LAD largely overlap with those of AL-LAD and LSD, users frequently report a significantly shorter duration and reduced discomfort in terms of negative physical side effects and anxiety. Some individuals have suggested that this compound could serve as an effective introductory psychedelic, alongside other shorter-lasting and more manageable psychedelics like 2C-B or 4-HO-MET.

1cP-AL-LAD 150mcg Blotters is for research use only and not intended for human consumption!

---

1cP-AL-LAD 150mcg Blotters stock last updated at: April 2025